Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in …
Background: Persistent low-level viraemia (PLLV) is a risk factor for virologic failure among
people receiving antiretroviral therapy (ART). Objectives: We assessed the prevalence and …
people receiving antiretroviral therapy (ART). Objectives: We assessed the prevalence and …
Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in …
O Onwah, E Nwanja, U Akpan… - Therapeutic …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Persistent low-level viraemia (PLLV) is a risk factor for virologic failure among
people receiving antiretroviral therapy (ART). Objectives We assessed the prevalence and …
people receiving antiretroviral therapy (ART). Objectives We assessed the prevalence and …
Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in …
O Onwah, E Nwanja, U Akpan, O Toyo… - … in Infectious Disease, 2024 - europepmc.org
Background Persistent low-level viraemia (PLLV) is a risk factor for virologic failure among
people receiving antiretroviral therapy (ART). Objectives We assessed the prevalence and …
people receiving antiretroviral therapy (ART). Objectives We assessed the prevalence and …
[HTML][HTML] Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy …
O Onwah, E Nwanja, U Akpan, O Toyo… - … in Infectious Disease, 2024 - ncbi.nlm.nih.gov
Background: Persistent low-level viraemia (PLLV) is a risk factor for virologic failure among
people receiving antiretroviral therapy (ART). Objectives: We assessed the prevalence and …
people receiving antiretroviral therapy (ART). Objectives: We assessed the prevalence and …
Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in …
O Onwah, E Nwanja, U Akpan, O Toyo… - … in Infectious Disease, 2024 - europepmc.org
Background Persistent low-level viraemia (PLLV) is a risk factor for virologic failure among
people receiving antiretroviral therapy (ART). Objectives We assessed the prevalence and …
people receiving antiretroviral therapy (ART). Objectives We assessed the prevalence and …